Terms: = Lung cancer AND FES, FPS, 2242, ENSG00000182511, P07332 AND Prognosis
9 results:
1. In silico analysis reveals PRR11 as a prognostic and oncogenic marker in lung adenocarcinoma.
Hu A; Tang K; Liu J; Han X; Chen Q
Medicine (Baltimore); 2023 May; 102(21):e33755. PubMed ID: 37233443
[TBL] [Abstract] [Full Text] [Related]
2. Development and Validation of a Nomogram for Predicting the 1-, 3-, and 5-year Survival in Patients with Acinar-predominant lung Adenocarcinoma.
Zuo ZC; Wang LD; Peng K; Yang J; Li X; Zhong Z; Zhang HM; Ouyang X; Xue Q
Curr Med Sci; 2022 Dec; 42(6):1178-1185. PubMed ID: 36542324
[TBL] [Abstract] [Full Text] [Related]
3. Association of Smoking With Patient Characteristics and Outcomes in Small Cell lung Carcinoma, 2011-2018.
Tseng JS; Chiang CJ; Chen KC; Zheng ZR; Yang TY; Lee WC; Hsu KH; Huang YH; Liu TW; Hsia JY; Chang GC
JAMA Netw Open; 2022 Mar; 5(3):e224830. PubMed ID: 35353165
[TBL] [Abstract] [Full Text] [Related]
4. Pulmonary metastases in newly diagnosed hepatocellular carcinoma: a population-based retrospective study.
Feng J; He Y; Wan J; Chen Z
HPB (Oxford); 2020 Sep; 22(9):1295-1304. PubMed ID: 31892468
[TBL] [Abstract] [Full Text] [Related]
5. Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients.
Wang Y; Liu H; Hou Y; Zhou X; Liang L; Zhang Z; Shi H; Xu S; Hu P; Zheng Z; Liu R; Tang T; Ye F; Liang Z; Bu H
Virchows Arch; 2018 Jun; 472(6):959-968. PubMed ID: 29705968
[TBL] [Abstract] [Full Text] [Related]
6. The predictive value of
Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML
Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034
[TBL] [Abstract] [Full Text] [Related]
7. [Multi-factor retrospective study in 91 small cell lung cancer patients].
Liu Y; Zhu J; Liu X; Xin Y; Wang Y; Cheng Y
Zhongguo Fei Ai Za Zhi; 2014 Aug; 17(8):588-95. PubMed ID: 25130964
[TBL] [Abstract] [Full Text] [Related]
8. [Expression of multidrug resistance-associated protein in human non-small cell lung cancer].
Peng X; Feng F; Zhang W
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Nov; 22(11):655-8. PubMed ID: 11776518
[TBL] [Abstract] [Full Text] [Related]
9. Clinical and histopathologic evaluation of the expression of Ha-ras and fes oncogene products in lung cancer.
Nishio H; Nakamura S; Horai T; Ikegami H; Matsuda M
Cancer; 1992 Mar; 69(5):1130-6. PubMed ID: 1310887
[TBL] [Abstract] [Full Text] [Related]
